Jeffrey Wang
- Virology top 0.5%
- Infectious Diseases top 2%
- Immunology top 10%
- Molecular Biology
- Epidemiology
- Co-authors
- Ya‐Chi HoDaniel I. S. RosenbloomJanet D. SilicianoNina N. HosmaneSarah B. LaskeyLiang ShanJoel N. BlanksonRobert F. Siliciano
- Topics
- PARP inhibition in cancer therapy (5 papers)Immune Cell Function and Interaction (2 papers)HIV/AIDS drug development and treatment (2 papers)
- Partner nations
- United StatesEgyptNetherlands
In The Last Decade
Jeffrey Wang
14 papers receiving 1.3k citations
Hit Papers
Peers
Comparison fields: 5 of 77
- Virology 943
- Infectious Diseases 638
- Immunology 364
- Molecular Biology 314
- Epidemiology 200
Countries citing papers authored by Jeffrey Wang
This map shows the geographic impact of Jeffrey Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey Wang more than expected).
Fields of papers citing papers by Jeffrey Wang
This network shows the impact of papers produced by Jeffrey Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey Wang. The network helps show where Jeffrey Wang may publish in the future.
Co-authorship network of co-authors of Jeffrey Wang
This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey Wang. A scholar is included among the top collaborators of Jeffrey Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey Wang. Jeffrey Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 16 | |
| 2 | 3 | |
| 3 | 16 | |
| 4 | 13 | |
| 5 | 1 | |
| 6 | 43 | |
| 7 | 33 | |
| 8 | Replication-Competent Noninduced Proviruses in the Latent Reservoir Increase Barrier to HIV-1 Curebreakdown → | 1013 |
| 9 | 56 | |
| 10 | 16 | |
| 11 | 30 | |
| 12 | 26 | |
| 13 | 17 | |
| 14 | 25 |
About Jeffrey Wang
Jeffrey Wang is a scholar working on Complementary and Manual Therapy, Oncology and Otorhinolaryngology, having authored 14 papers that have together received 1.3k indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (5 papers), Immune Cell Function and Interaction (2 papers) and HIV/AIDS drug development and treatment (2 papers). The work is most often cited by research in Virology (943 citations), Infectious Diseases (638 citations) and Immunology (364 citations). Jeffrey Wang has collaborated with scholars based in United States, Egypt and Netherlands. Frequent co-authors include Ya‐Chi Ho, Daniel I. S. Rosenbloom, Janet D. Siliciano, Nina N. Hosmane, Sarah B. Laskey, Liang Shan, Joel N. Blankson, Robert F. Siliciano, Jun Lai and Ed Grabczyk. Their work appears in journals such as Cell, Journal of Biological Chemistry and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.